Page last updated: 2024-11-04

iodoacetic acid and Pain

iodoacetic acid has been researched along with Pain in 62 studies

Iodoacetic Acid: A derivative of ACETIC ACID that contains one IODINE atom attached to its methyl group.
iodoacetic acid : A haloacetic acid that is acetic acid in which one of the hydrogens of the methyl group is replaced by an iodine atom.

Pain: An unpleasant sensation induced by noxious stimuli which are detected by NERVE ENDINGS of NOCICEPTIVE NEURONS.

Research Excerpts

ExcerptRelevanceReference
"The results showed that Chrysin not only attenuated synovial inflammation but also reduced the secretion of pain-related factors and increased the PWT and cold pain threshold in rats."7.96Chrysin Attenuates the NLRP3 Inflammasome Cascade to Reduce Synovitis and Pain in KOA Rats. ( Ding, L; Li, X; Liao, T; Ma, Z; Wang, P; Wu, P; Xiao, Y; Xu, B; Zhang, H; Zhang, L, 2020)
"We established a monoiodoacetate (MIA)-induced rat OA model and evaluated the joint pain and cartilage damage with or without celastrol treatments."7.88Celastrol attenuates pain and cartilage damage via SDF-1/CXCR4 signalling pathway in osteoarthritis rats. ( Gong, M; Ha, C; Lin, T; Wang, D; Wang, W; Wang, Y, 2018)
" Cannabidiol (CBD) is a noneuphoria producing constituent of cannabis that has the potential to relieve pain."7.85Attenuation of early phase inflammation by cannabidiol prevents pain and nerve damage in rat osteoarthritis. ( McDougall, JJ; O'Brien, M; Philpott, HT, 2017)
" After daily administration of atorvastatin (3, 10 and 30 mg/kg) for 20 days by oral gavage, pain was assessed on days 0, 1, 3, 7, 14 and 21."7.81Effect of atorvastatin, a HMG-CoA reductase inhibitor in monosodium iodoacetate-induced osteoarthritic pain: implication for osteoarthritis therapy. ( Balaganur, V; Kant, V; Kumar, D; Lingaraju, MC; Pathak, NN; Sharma, AK; Tandan, SK, 2015)
"Acute oral toxicity of m-PGA resulted in LD50 values in excess of 2000 mg/kg."5.51Safety and efficacy of a new micronized formulation of the ALIAmide palmitoylglucosamine in preclinical models of inflammation and osteoarthritis pain. ( Cordaro, M; Crupi, R; Cuzzocrea, S; D' Amico, R; Di Paola, R; Fusco, R; Gugliandolo, E; Impellizzeri, D; Peritore, AF; Schievano, C; Siracusa, R, 2019)
" Both 27 and 48 demonstrated robust activity in the acute rat monoiodoacetate-induced osteoarthritis model of pain, and subchronic dosing of 48 showed a shift to a lower EC50 over 7 days."5.43Substituted Indazoles as Nav1.7 Blockers for the Treatment of Pain. ( Daanen, JF; DeGoey, DA; El-Kouhen, OF; Fricano, MM; Frost, JM; Ghoreishi-Haack, N; Gum, RJ; Hsieh, GC; Kort, ME; Lundgaard, GL; Matulenko, MA; Neelands, T; Pai, M; Shi, L; Zhan, C; Zhang, XF, 2016)
"The results showed that Chrysin not only attenuated synovial inflammation but also reduced the secretion of pain-related factors and increased the PWT and cold pain threshold in rats."3.96Chrysin Attenuates the NLRP3 Inflammasome Cascade to Reduce Synovitis and Pain in KOA Rats. ( Ding, L; Li, X; Liao, T; Ma, Z; Wang, P; Wu, P; Xiao, Y; Xu, B; Zhang, H; Zhang, L, 2020)
"We established a monoiodoacetate (MIA)-induced rat OA model and evaluated the joint pain and cartilage damage with or without celastrol treatments."3.88Celastrol attenuates pain and cartilage damage via SDF-1/CXCR4 signalling pathway in osteoarthritis rats. ( Gong, M; Ha, C; Lin, T; Wang, D; Wang, W; Wang, Y, 2018)
" Cannabidiol (CBD) is a noneuphoria producing constituent of cannabis that has the potential to relieve pain."3.85Attenuation of early phase inflammation by cannabidiol prevents pain and nerve damage in rat osteoarthritis. ( McDougall, JJ; O'Brien, M; Philpott, HT, 2017)
" After daily administration of atorvastatin (3, 10 and 30 mg/kg) for 20 days by oral gavage, pain was assessed on days 0, 1, 3, 7, 14 and 21."3.81Effect of atorvastatin, a HMG-CoA reductase inhibitor in monosodium iodoacetate-induced osteoarthritic pain: implication for osteoarthritis therapy. ( Balaganur, V; Kant, V; Kumar, D; Lingaraju, MC; Pathak, NN; Sharma, AK; Tandan, SK, 2015)
"Eplerenone treatment produced a significant improvement in motor coordination and spontaneous locomotor activity in rats and modulated the key inflammatory mediators in OA (TNF-α, NF-κβ, and IL-6)."1.91Eplerenone modulates the inflammatory response in monosodium iodoacetate-induced knee osteoarthritis in rats: Involvement of RANKL/OPG axis. ( Mostafa, RE; Salama, AAA, 2023)
"Pain is the most common symptom of osteoarthritis, and spinal glia is known to contribute to this symptom."1.72Investigation of the effects of therapeutic ultrasound or photobiomodulation and the role of spinal glial cells in osteoarthritis-induced nociception in mice. ( Elisei, L; Galdino, G; Malta, I; Moraes, T; Novaes, R, 2022)
"After osteoarthritis was induced by intra-articular injection of MIA, pain behavioral tests were performed."1.72Analgesic dorsal root ganglion field stimulation blocks both afferent and efferent spontaneous activity in sensory neurons of rats with monosodium iodoacetate-induced osteoarthritis. ( Chao, D; Hogan, QH; Pan, B; Tran, H, 2022)
"Acute oral toxicity of m-PGA resulted in LD50 values in excess of 2000 mg/kg."1.51Safety and efficacy of a new micronized formulation of the ALIAmide palmitoylglucosamine in preclinical models of inflammation and osteoarthritis pain. ( Cordaro, M; Crupi, R; Cuzzocrea, S; D' Amico, R; Di Paola, R; Fusco, R; Gugliandolo, E; Impellizzeri, D; Peritore, AF; Schievano, C; Siracusa, R, 2019)
"Bone pain is a prevalent issue in society today and also is one of the hardest types of pain to control."1.51Animal Models for the Study of Bone-Derived Pain. ( Largent-Milnes, TM; Thompson, AL; Vanderah, TW, 2019)
"Osteoarthritic pain is a chronic disabling condition lacking effective treatment."1.51Sigma-1 receptor modulates neuroinflammation associated with mechanical hypersensitivity and opioid tolerance in a mouse model of osteoarthritis pain. ( Cabañero, D; Carcolé, M; Dickenson, AH; Fernández-Pastor, B; Gonçalves, L; Kummer, S; Maldonado, R; Merlos, M; Zamanillo, D, 2019)
"Preventive AR786 treatment inhibited pain behaviour development and therapeutic treatment attenuated established pain behaviour."1.43Blocking the tropomyosin receptor kinase A (TrkA) receptor inhibits pain behaviour in two rat models of osteoarthritis. ( Chapman, V; Mapp, PI; Nwosu, LN; Walsh, DA, 2016)
" Both 27 and 48 demonstrated robust activity in the acute rat monoiodoacetate-induced osteoarthritis model of pain, and subchronic dosing of 48 showed a shift to a lower EC50 over 7 days."1.43Substituted Indazoles as Nav1.7 Blockers for the Treatment of Pain. ( Daanen, JF; DeGoey, DA; El-Kouhen, OF; Fricano, MM; Frost, JM; Ghoreishi-Haack, N; Gum, RJ; Hsieh, GC; Kort, ME; Lundgaard, GL; Matulenko, MA; Neelands, T; Pai, M; Shi, L; Zhan, C; Zhang, XF, 2016)
"To assess neural correlates of mechanical hyperalgesia, hindpaws were stimulated with von Frey hairs (8 g: MIA; 15 g: control knee, based on behavioral withdrawal responses)."1.43Neural correlates of hyperalgesia in the monosodium iodoacetate model of osteoarthritis pain. ( Abaei, M; Auer, DP; Chapman, V; Prior, M; Sagar, DR; Spicer, CH; Stockley, EG, 2016)
"The current treatments for OA pain such as NSAIDS or opiates are neither sufficiently effective nor devoid of detrimental side effects."1.43The Monoiodoacetate Model of Osteoarthritis Pain in the Mouse. ( Malcangio, M; Pitcher, T; Sousa-Valente, J, 2016)
"Although analgesic approaches targeting nerve growth factor (NGF) for the treatment of osteoarthritis (OA) pain remain of clinical interest, neurophysiological mechanisms by which NGF contribute to OA pain remain unclear."1.42Dissecting the contribution of knee joint NGF to spinal nociceptive sensitization in a model of OA pain in the rat. ( Chapman, V; Nwosu, L; Sagar, DR; Walsh, DA, 2015)
"Osteoarthritis was produced by single intra-articular injection of the MIA in the right knee joint on day 0."1.39Effect of iNOS inhibitor S-methylisothiourea in monosodium iodoacetate-induced osteoathritic pain: implication for osteoarthritis therapy. ( Balaganur, V; Gupta, G; Kumar, D; Kumari, RR; Lingaraju, MC; More, AS; Pathak, NN; Sharma, AK; Tandan, SK, 2013)
"MIA injection produced thermal hyperalgesia (assessed by the plantar test) and tactile allodynia (measured with von Frey hairs)."1.35Increased gene expression and production of spinal cyclooxygenase 1 and 2 during experimental osteoarthritis pain. ( Dolezal, T; Krsiak, M; Prochazkova, M; Prokesova, L; Zanvit, P, 2009)

Research

Studies (62)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (1.61)29.6817
2010's35 (56.45)24.3611
2020's26 (41.94)2.80

Authors

AuthorsStudies
Malta, I1
Moraes, T1
Elisei, L1
Novaes, R1
Galdino, G1
Lee, M1
Kim, GH1
Kim, M1
Seo, JM1
Kim, YM1
Seon, MR1
Um, S1
Choi, SJ1
Oh, W1
Song, BR1
Jin, HJ1
Zhang, X1
Chen, R1
Liao, Z1
Zhu, Y1
Chen, Y1
Liu, J1
Chen, X1
Han, FY1
Brockman, DA1
Nicholson, JR1
Corradini, L1
Smith, MT1
Lee, YM1
Son, E1
Kim, SH1
Kim, DS1
Chao, D1
Tran, H1
Hogan, QH1
Pan, B1
Na, HS3
Lee, SY3
Lee, DH1
Woo, JS1
Choi, SY2
Cho, KH3
Kim, SA2
Go, EJ2
Lee, AR1
Choi, JW1
Kim, SJ4
Cho, ML7
Arai, T1
Suzuki-Narita, M1
Takeuchi, J1
Tajiri, I1
Inage, K2
Kawarai, Y1
Eguchi, Y1
Shiga, Y1
Hozumi, T1
Kim, G1
Tsuchiya, R1
Otagiri, T1
Mukaihata, T1
Hishiya, T1
Toshi, N1
Okuyama, K1
Tokeshi, S1
Furuya, T1
Maki, S1
Matsuura, Y1
Suzuki, T3
Nakamura, J3
Hagiwara, S2
Ohtori, S3
Orita, S3
Sriwatananukulkit, O2
Desclaux, S2
Tawonsawatruk, T2
Srikuea, R2
Himakhun, W2
Likitnukul, S2
Hemstapat, R2
Jin, H1
Yang, Y1
Lei, G1
Zeng, C1
He, K1
Wang, Y2
Deng, C1
Wei, J2
Li, X3
Li, H2
Mostafa, RE1
Salama, AAA1
Barry, F1
Chai, F1
Chijcheapaza-Flores, H1
Garcia-Fernandez, MJ1
Blanchemain, N1
Nicot, R1
Kwon, M1
Nam, D1
Kim, J2
Wang, X1
Song, J1
Xia, P1
Lin, Q1
Chen, A1
Cheng, K1
Kong, F1
Shi, Y1
Yun, SY1
Kim, Y2
Kim, H2
Lee, BK1
Oh, DK1
Jhun, JY2
Lee, JS1
Um, IG1
Park, MS1
Park, SH6
Sun, J1
Wang, XH1
Song, FH1
Li, DY1
Gao, SJ1
Zhang, LQ1
Wu, JY1
Liu, DQ1
Wang, LW1
Zhou, YQ1
Mei, W1
Cordaro, M1
Siracusa, R1
Impellizzeri, D1
D' Amico, R1
Peritore, AF1
Crupi, R1
Gugliandolo, E1
Fusco, R1
Di Paola, R1
Schievano, C1
Cuzzocrea, S1
Li, Y1
Wu, F1
Lao, L1
Shen, X1
Sa, L1
Wei, X1
Huang, Q1
Cai, Y1
Lu, D1
Mei, R1
Hu, X1
Lee, D1
Ju, MK1
Micheli, L2
Di Cesare Mannelli, L2
Mattoli, L1
Tamimi, S1
Flamini, E1
Garetto, S1
Lucci, J1
Giovagnoni, E1
Cinci, L1
D'Ambrosio, M1
Luceri, C1
Ghelardini, C2
Xu, J1
Yan, L3
Yan, B2
Zhou, L3
Tong, P3
Shan, L3
Liao, T1
Ding, L1
Wu, P1
Zhang, L1
Xu, B1
Zhang, H1
Ma, Z1
Xiao, Y1
Wang, P1
Bryk, M1
Chwastek, J1
Kostrzewa, M1
Mlost, J1
Pędracka, A1
Starowicz, K1
da Silva Nascimento, FG1
de Souza Ferreira Bringel, PH1
Maia, FWS1
Lima, CPC1
Alves, RC1
Feitosa, JPA1
Mota, MRL1
Assreuy, AMS1
Castro, RR1
Park, H1
Hong, J1
Yin, Y1
Joo, Y1
Shin, J1
Kwon, HH1
Shin, N1
Shin, HJ1
Beom, J1
Kim, DW1
Lucarini, E1
Cialdai, F1
Vignali, L1
Monici, M1
Park, YJ1
Cho, YR1
Oh, JS1
Ahn, EK1
Philpott, HT1
O'Brien, M1
McDougall, JJ1
Wang, W1
Ha, C1
Lin, T1
Wang, D1
Gong, M1
Shetty, YC1
Godbharle, S1
Brahma, S1
Salgaonkar, S1
Rege, NN1
Ichiseki, T1
Shimazaki, M1
Ueda, Y1
Ueda, S1
Tsuchiya, M1
Souma, D1
Kaneuji, A1
Kawahara, N1
Kwon, JY3
Lee, SH3
Jhun, J3
Choi, J1
Jung, K3
Yang, CW2
Hinata, M1
Imai, S1
Sanaki, T2
Tsuchida, J1
Yoshioka, T2
Higashino, K2
Yamamoto, M1
Imai, M1
Soga, M1
Horita, N1
Fukuda, I1
Ikeda, M1
Yamane, S1
Morita, A1
Kanemasa, T1
Sakaguchi, G1
Hasegawa, M2
Minami, M1
Morioka, Y2
Karlapudi, V1
Prasad Mungara, AVV1
Sengupta, K1
Davis, BA1
Raychaudhuri, SP1
Haywood, AR1
Hathway, GJ1
Chapman, V4
Cho, Y1
Wang, C1
Sun, W1
Yu, L1
Liu, F2
Du, W2
Yu, G1
Hu, Z1
Yuan, Q2
Xiao, L1
Zhang, J1
Efferth, T2
Sakurai, Y1
Fujita, M1
Kawasaki, S1
Tofukuji, S1
Yoneda, S1
Takahashi, T1
Koda, K1
Asaki, T1
Kim, GY1
Park, MJ1
Baek, JA1
Thompson, AL1
Largent-Milnes, TM1
Vanderah, TW1
Xie, D1
Chen, F1
Carcolé, M1
Kummer, S1
Gonçalves, L1
Zamanillo, D1
Merlos, M1
Dickenson, AH1
Fernández-Pastor, B1
Cabañero, D1
Maldonado, R1
Lee, J1
Hong, YS1
Jeong, JH2
Yang, EJ2
Park, MK2
Jung, YO1
Min, JK2
Kim, HY2
Ishikawa, G1
Nagakura, Y1
Takeshita, N2
Shimizu, Y2
Sagar, DR2
Nwosu, L1
Walsh, DA2
Pathak, NN2
Balaganur, V2
Lingaraju, MC2
Kant, V1
Kumar, D4
Sharma, AK2
Tandan, SK2
Nwosu, LN1
Mapp, PI1
Taniguchi, A1
Ishikawa, T1
Miyagi, M1
Kamoda, H1
Sakuma, Y1
Oikawa, Y1
Kubota, G1
Sainoh, T1
Aoki, Y1
Toyone, T1
Inoue, G1
Suzuki, M2
Yamauchi, K1
Takahashi, K2
Frost, JM1
DeGoey, DA1
Shi, L1
Gum, RJ1
Fricano, MM1
Lundgaard, GL1
El-Kouhen, OF1
Hsieh, GC1
Neelands, T1
Matulenko, MA1
Daanen, JF1
Pai, M1
Ghoreishi-Haack, N1
Zhan, C1
Zhang, XF1
Kort, ME1
Abaei, M1
Stockley, EG1
Spicer, CH1
Prior, M1
Auer, DP1
Pitcher, T1
Sousa-Valente, J1
Malcangio, M1
Otis, C1
Gervais, J1
Guillot, M1
Gervais, JA1
Gauvin, D1
Péthel, C1
Authier, S1
Dansereau, MA1
Sarret, P1
Martel-Pelletier, J1
Pelletier, JP1
Beaudry, F2
Troncy, E1
Miyamoto, S1
Nakajima, T1
Omae, T1
Takazawa, M1
Prochazkova, M1
Zanvit, P1
Dolezal, T1
Prokesova, L1
Krsiak, M1
Yoshimi, E1
Hatori, C1
Kumakura, F1
Seki, N1
Ferland, CE1
Pailleux, F1
Vachon, P1
Izumi, M1
Ikeuchi, M1
Ji, Q1
Tani, T1
More, AS1
Kumari, RR1
Gupta, G1
Moon, SJ1
Park, JS1
Kim, EK1
Shao, H1
Han, G1
Ling, P1
Zhu, X1
Wang, F1
Zhao, L1
Liu, X1
Wang, G1
Ying, Y1
Zhang, T1

Clinical Trials (2)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
The Use of Cannabinoid Patch for Knee Osteoarthritis[NCT04412837]Phase 20 participants (Actual)Interventional2022-10-31Withdrawn (stopped due to Inadequate funding)
Randomized Controlled Trial of Exercise Therapy in Combination With Central Nervous System-targeted Treatment Compared With Exercise Therapy Alone for Treatment of People With Knee Osteoarthritis[NCT03681613]104 participants (Anticipated)Interventional2019-01-07Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

1 review available for iodoacetic acid and Pain

ArticleYear
Pain Intensity and Trajectory Following Intra-Articular Injection of Mono-Iodoacetate in Experimental Osteoarthritis: A Meta-Analysis of
    Cartilage, 2023, Volume: 14, Issue:1

    Topics: Animals; Injections, Intra-Articular; Iodoacetic Acid; Osteoarthritis; Pain; Pain Measurement; Rats

2023

Trials

1 trial available for iodoacetic acid and Pain

ArticleYear
A Placebo-Controlled Double-Blind Study Demonstrates the Clinical Efficacy of a Novel Herbal Formulation for Relieving Joint Discomfort in Human Subjects with Osteoarthritis of Knee.
    Journal of medicinal food, 2018, Volume: 21, Issue:5

    Topics: Aged; Animals; Body Mass Index; Body Weight; Boswellia; Curcuma; Cytokines; Disease Models, Animal;

2018

Other Studies

60 other studies available for iodoacetic acid and Pain

ArticleYear
Investigation of the effects of therapeutic ultrasound or photobiomodulation and the role of spinal glial cells in osteoarthritis-induced nociception in mice.
    Lasers in medical science, 2022, Volume: 37, Issue:3

    Topics: Animals; Disease Models, Animal; Iodoacetic Acid; Male; Mice; Neuroglia; Nociception; Osteoarthritis

2022
PTX-3 Secreted by Intra-Articular-Injected SMUP-Cells Reduces Pain in an Osteoarthritis Rat Model.
    Cells, 2021, 09-14, Volume: 10, Issue:9

    Topics: Animals; C-Reactive Protein; Cytokines; Disease Models, Animal; Inflammation; Injections, Intra-Arti

2021
The Xiaogu San Attenuates Pain and Cartilage Damage in Rats with Monosodium Iodoacetate Induced Osteoarthritis.
    Combinatorial chemistry & high throughput screening, 2022, Volume: 25, Issue:11

    Topics: Animals; Cartilage, Articular; Cytokines; Disease Models, Animal; Iodoacetic Acid; Osteoarthritis; P

2022
Gait analysis as a robust pain behavioural endpoint in the chronic phase of the monoiodoacetate-induced knee joint pain in the rat.
    Behavioural pharmacology, 2022, 02-01, Volume: 33, Issue:1

    Topics: Animals; Arthralgia; Behavior Observation Techniques; Behavior, Animal; Behavioral Symptoms; Disease

2022
Anti-Inflammatory and Analgesic Effects of
    Nutrients, 2022, Mar-24, Volume: 14, Issue:7

    Topics: Acetic Acid; Analgesics; Animals; Anti-Inflammatory Agents; Iodoacetic Acid; Lipopolysaccharides; Mi

2022
Analgesic dorsal root ganglion field stimulation blocks both afferent and efferent spontaneous activity in sensory neurons of rats with monosodium iodoacetate-induced osteoarthritis.
    Osteoarthritis and cartilage, 2022, Volume: 30, Issue:11

    Topics: Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Disease Models, Animal; Ganglia, Spina

2022
Soluble CCR2 gene therapy controls joint inflammation, cartilage damage, and the progression of osteoarthritis by targeting MCP-1 in a monosodium iodoacetate (MIA)-induced OA rat model.
    Journal of translational medicine, 2022, 09-23, Volume: 20, Issue:1

    Topics: Amino Acids; Animals; Anti-Inflammatory Agents; Cartilage; Cartilage, Articular; Chemokine CCL2; Dis

2022
Analgesic effects and arthritic changes following intra-articular injection of diclofenac etalhyaluronate in a rat knee osteoarthritis model.
    BMC musculoskeletal disorders, 2022, Nov-07, Volume: 23, Issue:1

    Topics: Analgesics; Animals; Calcitonin Gene-Related Peptide; Diclofenac; Disease Models, Animal; Hyaluronic

2022
Effectiveness of losartan on infrapatellar fat pad/synovial fibrosis and pain behavior in the monoiodoacetate-induced rat model of osteoarthritis pain.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2023, Volume: 158

    Topics: Adipose Tissue; Angiotensin II Type 1 Receptor Blockers; Animals; Fibrosis; Iodoacetic Acid; Losarta

2023
Effectiveness of losartan on infrapatellar fat pad/synovial fibrosis and pain behavior in the monoiodoacetate-induced rat model of osteoarthritis pain.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2023, Volume: 158

    Topics: Adipose Tissue; Angiotensin II Type 1 Receptor Blockers; Animals; Fibrosis; Iodoacetic Acid; Losarta

2023
Effectiveness of losartan on infrapatellar fat pad/synovial fibrosis and pain behavior in the monoiodoacetate-induced rat model of osteoarthritis pain.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2023, Volume: 158

    Topics: Adipose Tissue; Angiotensin II Type 1 Receptor Blockers; Animals; Fibrosis; Iodoacetic Acid; Losarta

2023
Effectiveness of losartan on infrapatellar fat pad/synovial fibrosis and pain behavior in the monoiodoacetate-induced rat model of osteoarthritis pain.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2023, Volume: 158

    Topics: Adipose Tissue; Angiotensin II Type 1 Receptor Blockers; Animals; Fibrosis; Iodoacetic Acid; Losarta

2023
Eplerenone modulates the inflammatory response in monosodium iodoacetate-induced knee osteoarthritis in rats: Involvement of RANKL/OPG axis.
    Life sciences, 2023, Mar-01, Volume: 316

    Topics: Animals; Cartilage, Articular; Disease Models, Animal; Eplerenone; Humans; Inflammation; Iodoacetic

2023
Comparison of chemical-induced temporomandibular osteoarthritis rat models (monosodium iodoacetate versus collagenase type II) for the study of prolonged drug delivery systems.
    PloS one, 2023, Volume: 18, Issue:1

    Topics: Animals; Arthralgia; Collagenases; Disease Models, Animal; Drug Delivery Systems; Injections, Intra-

2023
Pathological Characteristics of Monosodium Iodoacetate-Induced Osteoarthritis in Rats.
    Tissue engineering and regenerative medicine, 2023, Volume: 20, Issue:3

    Topics: Animals; Arthritis, Experimental; Inflammation; Iodoacetic Acid; Male; Osteoarthritis; Pain; Rats; X

2023
High intensity interval training attenuates osteoarthritis-associated hyperalgesia in rats.
    The journal of physiological sciences : JPS, 2023, Apr-28, Volume: 73, Issue:1

    Topics: Animals; Disease Models, Animal; High-Intensity Interval Training; Hyperalgesia; Iodoacetic Acid; Os

2023
Effective Technical Protocol for Producing a Mono-Iodoacetate-Induced Temporomandibular Joint Osteoarthritis in a Rat Model.
    Tissue engineering. Part C, Methods, 2023, Volume: 29, Issue:9

    Topics: Animals; Bone Remodeling; Disease Models, Animal; Iodoacetic Acid; Osteoarthritis; Pain; Rats; Tempo

2023
Bifidobacterium longum BORI inhibits pain behavior and chondrocyte death, and attenuates osteoarthritis progression.
    PloS one, 2023, Volume: 18, Issue:6

    Topics: Animals; Cartilage, Articular; Chondrocytes; Cytokines; Inflammation; Iodoacetic Acid; Osteoarthriti

2023
Inhibition of Brd4 alleviates osteoarthritis pain via suppression of neuroinflammation and activation of Nrf2-mediated antioxidant signalling.
    British journal of pharmacology, 2023, Volume: 180, Issue:24

    Topics: Animals; Antioxidants; Disease Models, Animal; Humans; Hyperalgesia; Iodoacetic Acid; Neuroinflammat

2023
Safety and efficacy of a new micronized formulation of the ALIAmide palmitoylglucosamine in preclinical models of inflammation and osteoarthritis pain.
    Arthritis research & therapy, 2019, 11-28, Volume: 21, Issue:1

    Topics: Analgesics; Animals; Carrageenan; Female; Glucosamine; Hyperalgesia; Inflammation; Iodoacetic Acid;

2019
Laser Moxibustion Alleviates Knee Osteoarthritis Pain by Inhibiting Spinal Microglial Activation-Mediated Neuroinflammation in Rats.
    Photobiomodulation, photomedicine, and laser surgery, 2020, Volume: 38, Issue:4

    Topics: Animals; Cytokines; Disease Models, Animal; Iodoacetic Acid; Low-Level Light Therapy; Male; Microgli

2020
Contribution of salidroside to the relieve of symptom and sign in the early acute stage of osteoarthritis in rat model.
    Journal of ethnopharmacology, 2020, Sep-15, Volume: 259

    Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Cartilage, Articular; Chondrocytes; Cytokines; Fema

2020
Commiphora Extract Mixture Ameliorates Monosodium Iodoacetate-Induced Osteoarthritis.
    Nutrients, 2020, May-19, Volume: 12, Issue:5

    Topics: Acetic Acid; Analgesics; Animals; Anti-Inflammatory Agents; Arthritis, Experimental; Cartilage, Arti

2020
Intra-Articular Route for the System of Molecules 14G1862 from
    Nutrients, 2020, May-31, Volume: 12, Issue:6

    Topics: Analgesics; Animals; Arthritis, Experimental; Cell Survival; Centella; Disease Models, Animal; Hyper

2020
Osteoarthritis Pain Model Induced by Intra-Articular Injection of Mono-Iodoacetate in Rats.
    Journal of visualized experiments : JoVE, 2020, 05-20, Issue:159

    Topics: Animals; Cartilage, Articular; Chondrocytes; Cytokines; Disease Models, Animal; Injections, Intra-Ar

2020
Chrysin Attenuates the NLRP3 Inflammasome Cascade to Reduce Synovitis and Pain in KOA Rats.
    Drug design, development and therapy, 2020, Volume: 14

    Topics: Animals; Anti-Inflammatory Agents; Drugs, Chinese Herbal; Flavonoids; Inflammasomes; Iodoacetic Acid

2020
Alterations in Anandamide Synthesis and Degradation during Osteoarthritis Progression in an Animal Model.
    International journal of molecular sciences, 2020, Oct-06, Volume: 21, Issue:19

    Topics: Animals; Arachidonic Acids; Disease Models, Animal; Disease Progression; Endocannabinoids; Gene Expr

2020
Galactomannan of Delonix regia seeds reduces nociception and morphological damage in the rat model of osteoarthritis induced by sodium monoiodoacetate.
    Naunyn-Schmiedeberg's archives of pharmacology, 2021, Volume: 394, Issue:3

    Topics: Analgesics; Animals; Disease Models, Animal; Fabaceae; Foot Joints; Galactose; Iodoacetic Acid; Male

2021
TAP2, a peptide antagonist of Toll-like receptor 4, attenuates pain and cartilage degradation in a monoiodoacetate-induced arthritis rat model.
    Scientific reports, 2020, 10-15, Volume: 10, Issue:1

    Topics: Animals; Arthritis, Experimental; ATP Binding Cassette Transporter, Subfamily B, Member 3; Cartilage

2020
Photobiomodulation therapy by NIR laser in persistent pain: an analytical study in the rat.
    Lasers in medical science, 2017, Volume: 32, Issue:8

    Topics: Animals; Disease Models, Animal; Freund's Adjuvant; Inflammation; Infrared Rays; Injections, Intra-A

2017
Effects of Tribulus terrestris on monosodium iodoacetate‑induced osteoarthritis pain in rats.
    Molecular medicine reports, 2017, Volume: 16, Issue:4

    Topics: Animals; Bone and Bones; Cartilage; Cyclooxygenase 2; Cytokines; Disease Models, Animal; Female; Inf

2017
Attenuation of early phase inflammation by cannabidiol prevents pain and nerve damage in rat osteoarthritis.
    Pain, 2017, Volume: 158, Issue:12

    Topics: Animals; Arthralgia; Cannabidiol; Disease Models, Animal; Inflammation; Iodoacetic Acid; Knee Joint;

2017
Celastrol attenuates pain and cartilage damage via SDF-1/CXCR4 signalling pathway in osteoarthritis rats.
    The Journal of pharmacy and pharmacology, 2018, Volume: 70, Issue:1

    Topics: Animals; Anti-Inflammatory Agents; Arthritis, Experimental; Cartilage, Articular; Chemokine CXCL12;

2018
Evaluation of oral multi-herbal preparation of Dashmoolarishta on mice model of osteoarthritis.
    Journal of basic and clinical physiology and pharmacology, 2017, Nov-27, Volume: 28, Issue:6

    Topics: Animals; Arthritis, Experimental; Behavior, Animal; Female; Hyaluronic Acid; Iodoacetic Acid; Male;

2017
Intraarticularly-Injected Mesenchymal Stem Cells Stimulate Anti-Inflammatory Molecules and Inhibit Pain Related Protein and Chondrolytic Enzymes in a Monoiodoacetate-Induced Rat Arthritis Model.
    International journal of molecular sciences, 2018, Jan-09, Volume: 19, Issue:1

    Topics: ADAMTS5 Protein; Animals; Calcitonin Gene-Related Peptide; Cartilage, Articular; Cell Adhesion Molec

2018
The Combination of Probiotic Complex, Rosavin, and Zinc Improves Pain and Cartilage Destruction in an Osteoarthritis Rat Model.
    Journal of medicinal food, 2018, Volume: 21, Issue:4

    Topics: Animals; Anti-Inflammatory Agents; Arthritis, Experimental; Cartilage, Articular; Chondrocytes; Cyto

2018
Sensitization of transient receptor potential vanilloid 4 and increasing its endogenous ligand 5,6-epoxyeicosatrienoic acid in rats with monoiodoacetate-induced osteoarthritis.
    Pain, 2018, Volume: 159, Issue:5

    Topics: Animals; Arthritis, Experimental; Disease Models, Animal; Ganglia, Spinal; Hand Strength; Iodoacetic

2018
Differential contributions of peripheral and central mechanisms to pain in a rodent model of osteoarthritis.
    Scientific reports, 2018, 05-08, Volume: 8, Issue:1

    Topics: Anesthetics, Local; Animals; Disease Models, Animal; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Gene Expre

2018
Lactobacillus acidophilus ameliorates pain and cartilage degradation in experimental osteoarthritis.
    Immunology letters, 2018, Volume: 203

    Topics: Animals; Cartilage; Chondrocytes; Iodoacetic Acid; Lactobacillus acidophilus; Male; Osteoarthritis;

2018
Agkistrodon ameliorates pain response and prevents cartilage degradation in monosodium iodoacetate-induced osteoarthritic rats by inhibiting chondrocyte hypertrophy and apoptosis.
    Journal of ethnopharmacology, 2019, Mar-01, Volume: 231

    Topics: Agkistrodon; Analgesics; Animals; Apoptosis; Cartilage, Articular; Chondrocytes; Complex Mixtures; H

2019
Contribution of synovial macrophages to rat advanced osteoarthritis pain resistant to cyclooxygenase inhibitors.
    Pain, 2019, Volume: 160, Issue:4

    Topics: Animals; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cytokines; Dinoprostone; Disease

2019
The Therapeutic Effect of STAT3 Signaling-Suppressed MSC on Pain and Articular Cartilage Damage in a Rat Model of Monosodium Iodoacetate-Induced Osteoarthritis.
    Frontiers in immunology, 2018, Volume: 9

    Topics: Administration, Intravenous; Animals; Arthritis, Experimental; Cartilage, Articular; Cells, Cultured

2018
Animal Models for the Study of Bone-Derived Pain.
    Methods in molecular biology (Clifton, N.J.), 2019, Volume: 1914

    Topics: Animals; Behavior, Animal; Bone and Bones; Bone Neoplasms; Cell Culture Techniques; Cell Line, Tumor

2019
Chondroprotective effects of platelet lysate towards monoiodoacetate-induced arthritis by suppression of TNF-α-induced activation of NF-ĸB pathway in chondrocytes.
    Aging, 2019, 05-14, Volume: 11, Issue:9

    Topics: Analgesics; Animals; Arthritis; Blood Platelets; Cell Survival; Chondrocytes; Gene Expression Regula

2019
Sigma-1 receptor modulates neuroinflammation associated with mechanical hypersensitivity and opioid tolerance in a mouse model of osteoarthritis pain.
    British journal of pharmacology, 2019, Volume: 176, Issue:20

    Topics: Analgesics, Opioid; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Toleranc

2019
Coenzyme Q10 ameliorates pain and cartilage degradation in a rat model of osteoarthritis by regulating nitric oxide and inflammatory cytokines.
    PloS one, 2013, Volume: 8, Issue:7

    Topics: Analgesics; Animals; Cartilage; Cytokines; Disease Models, Animal; Gene Expression Regulation; Infla

2013
Efficacy of drugs with different mechanisms of action in relieving spontaneous pain at rest and during movement in a rat model of osteoarthritis.
    European journal of pharmacology, 2014, Sep-05, Volume: 738

    Topics: Anesthetics, Local; Animals; Anti-Inflammatory Agents, Non-Steroidal; Disease Models, Animal; Duloxe

2014
Dissecting the contribution of knee joint NGF to spinal nociceptive sensitization in a model of OA pain in the rat.
    Osteoarthritis and cartilage, 2015, Volume: 23, Issue:6

    Topics: Animals; Arthritis, Experimental; Behavior, Animal; Injections, Intra-Articular; Iodoacetic Acid; Ma

2015
Effect of atorvastatin, a HMG-CoA reductase inhibitor in monosodium iodoacetate-induced osteoarthritic pain: implication for osteoarthritis therapy.
    Pharmacological reports : PR, 2015, Volume: 67, Issue:3

    Topics: Animals; Atorvastatin; Dose-Response Relationship, Drug; Hydroxymethylglutaryl-CoA Reductase Inhibit

2015
Blocking the tropomyosin receptor kinase A (TrkA) receptor inhibits pain behaviour in two rat models of osteoarthritis.
    Annals of the rheumatic diseases, 2016, Volume: 75, Issue:6

    Topics: Analgesics, Non-Narcotic; Animals; Arthritis, Experimental; Drug Evaluation, Preclinical; Iodoacetic

2016
Decreased calcitonin gene-related peptide expression in the dorsal root ganglia of TNF-deficient mice in a monoiodoacetate-induced knee osteoarthritis model.
    International journal of clinical and experimental pathology, 2015, Volume: 8, Issue:10

    Topics: Animals; Arthritis, Experimental; Calcitonin Gene-Related Peptide; Disease Models, Animal; Enzyme In

2015
Substituted Indazoles as Nav1.7 Blockers for the Treatment of Pain.
    Journal of medicinal chemistry, 2016, Apr-14, Volume: 59, Issue:7

    Topics: Analgesics; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Electrophysiology; Ev

2016
Neural correlates of hyperalgesia in the monosodium iodoacetate model of osteoarthritis pain.
    Molecular pain, 2016, Volume: 12

    Topics: Animals; Behavior, Animal; Brain; Brain Mapping; Capsaicin; Disease Models, Animal; Electric Stimula

2016
The Monoiodoacetate Model of Osteoarthritis Pain in the Mouse.
    Journal of visualized experiments : JoVE, 2016, 05-16, Issue:111

    Topics: Animals; Arthritis, Experimental; Behavior, Animal; Cartilage, Articular; Chondrocytes; Disease Mode

2016
Concurrent validity of different functional and neuroproteomic pain assessment methods in the rat osteoarthritis monosodium iodoacetate (MIA) model.
    Arthritis research & therapy, 2016, 06-23, Volume: 18

    Topics: Acclimatization; Animals; Arthritis, Experimental; Chromatography, High Pressure Liquid; Conditionin

2016
Pain-related behavior and the characteristics of dorsal-root ganglia in a rat model of hip osteoarthritis induced by mono-iodoacetate.
    Journal of orthopaedic research : official publication of the Orthopaedic Research Society, 2017, Volume: 35, Issue:7

    Topics: Animals; Arthritis, Experimental; Behavior, Animal; Calcitonin Gene-Related Peptide; Disease Models,

2017
Increased gene expression and production of spinal cyclooxygenase 1 and 2 during experimental osteoarthritis pain.
    Physiological research, 2009, Volume: 58, Issue:3

    Topics: Animals; Cyclooxygenase 1; Cyclooxygenase 2; Disease Models, Animal; Enzyme Induction; Hyperalgesia;

2009
Alleviating effects of AS1892802, a Rho kinase inhibitor, on osteoarthritic disorders in rodents.
    Journal of pharmacological sciences, 2011, Volume: 115, Issue:4

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Differentiation; Cell Line; Chondrocytes; Din

2011
Determination of specific neuropeptides modulation time course in a rat model of osteoarthritis pain by liquid chromatography ion trap mass spectrometry.
    Neuropeptides, 2011, Volume: 45, Issue:6

    Topics: Animals; Calcitonin Gene-Related Peptide; Chromatography, Liquid; Disease Models, Animal; Dynorphins

2011
Local ASIC3 modulates pain and disease progression in a rat model of osteoarthritis.
    Journal of biomedical science, 2012, Aug-21, Volume: 19

    Topics: Acid Sensing Ion Channels; Animals; Behavior, Animal; Cnidarian Venoms; Gene Expression Regulation;

2012
Effect of iNOS inhibitor S-methylisothiourea in monosodium iodoacetate-induced osteoathritic pain: implication for osteoarthritis therapy.
    Pharmacology, biochemistry, and behavior, 2013, Volume: 103, Issue:4

    Topics: Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Injections, Intra-Articular; Iodo

2013
Augmented chondroprotective effect of coadministration of celecoxib and rebamipide in the monosodium iodoacetate rat model of osteoarthritis.
    Archives of pharmacal research, 2013, Volume: 36, Issue:1

    Topics: Administration, Oral; Alanine; Animals; Arthritis, Experimental; Behavior, Animal; Cartilage; Celeco

2013
Intra-articular injection of xanthan gum reduces pain and cartilage damage in a rat osteoarthritis model.
    Carbohydrate polymers, 2013, Feb-15, Volume: 92, Issue:2

    Topics: Animals; Cartilage, Articular; Disease Models, Animal; Injections, Intra-Articular; Iodoacetic Acid;

2013